543 related articles for article (PubMed ID: 17997179)
1. Combination drugs, an emerging option for antibacterial therapy.
Cottarel G; Wierzbowski J
Trends Biotechnol; 2007 Dec; 25(12):547-55. PubMed ID: 17997179
[TBL] [Abstract][Full Text] [Related]
2. Nature's clarion call of antibacterial resistance: are we listening?
Theuretzbacher U; Toney JH
Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
[TBL] [Abstract][Full Text] [Related]
3. Late stage antibacterial drugs in the clinical pipeline.
Projan SJ; Bradford PA
Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics: where did we go wrong?
Overbye KM; Barrett JF
Drug Discov Today; 2005 Jan; 10(1):45-52. PubMed ID: 15676298
[TBL] [Abstract][Full Text] [Related]
5. Future antibiotics scenarios: is the tide starting to turn?
Theuretzbacher U
Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial drug discovery: is it all downhill from here?
Projan SJ; Shlaes DM
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial drug discovery in the 21st century.
Bush K
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():10-7. PubMed ID: 15522035
[TBL] [Abstract][Full Text] [Related]
9. Trends in antimicrobial drug development: implications for the future.
Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
[TBL] [Abstract][Full Text] [Related]
10. The need for new antibiotics.
Livermore DM
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
[TBL] [Abstract][Full Text] [Related]
11. Exploiting current understanding of antibiotic action for discovery of new drugs.
Chopra I; Hesse L; O'Neill AJ
J Appl Microbiol; 2002; 92 Suppl():4S-15S. PubMed ID: 12000608
[TBL] [Abstract][Full Text] [Related]
12. Novel target sites in bacteria for overcoming antibiotic resistance.
Black MT; Hodgson J
Adv Drug Deliv Rev; 2005 Jul; 57(10):1528-38. PubMed ID: 15949866
[TBL] [Abstract][Full Text] [Related]
13. Bacterial targets to antimicrobial leads and development candidates.
Rogers BL
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):211-22. PubMed ID: 15603255
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial drug discovery: is small pharma the solution?
Boggs AF; Miller GH
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial drug development--the past, the present, and the future.
Powers JH
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():23-31. PubMed ID: 15522037
[TBL] [Abstract][Full Text] [Related]
16. Can biotech deliver new antibiotics?
Barrett JF
Curr Opin Microbiol; 2005 Oct; 8(5):498-503. PubMed ID: 16125445
[TBL] [Abstract][Full Text] [Related]
17. Discovery research: the scientific challenge of finding new antibiotics.
Livermore DM;
J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626
[TBL] [Abstract][Full Text] [Related]
18. Role of bioinformatics in the development of new antibacterial therapy.
Bansal AK
Expert Rev Anti Infect Ther; 2008 Feb; 6(1):51-65. PubMed ID: 18251664
[TBL] [Abstract][Full Text] [Related]
19. The prospect for bacteriophage therapy in Western medicine.
Merril CR; Scholl D; Adhya SL
Nat Rev Drug Discov; 2003 Jun; 2(6):489-97. PubMed ID: 12776223
[TBL] [Abstract][Full Text] [Related]
20. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G; Rossolini GM
Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
